Levetiracetam EP Impurity A
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

67118-31-4Levetiracetam EP Impurity A

● In Stock

Catalogue No.:VL1280003
CAS No.:67118-31-4
Mol. Formula:C8H13NO3
Mol. Weight:171.19 g/mol

Additional information on CAS 67118-31-4

Parent drug

Levetiracetam

IUPAC Name

(2RS)-2-(2-Oxopyrrolidin-1-yl)butanoic acid

Pharmacopoeial Synonyms

N/A

Other Synonyms

2-(2-oxopyrrolidin-1-yl)butanoic Acid; Levetiracetam Carboxylic Acid Racemate;(S)-2-(2-Oxo-1-pyrrolidinyl)butanoic Acid

Smiles

CCC(N1C(CCC1)=O)C(O)=O

InChI

InChI=1S/C8H13NO3/c1-2-6(8(11)12)9-5-3-4-7(9)10/h6H,2-5H2,1H3,(H,11,12)

Description

Levetiracetam EP Impurity A, also designated levetiracetam carboxylic acid racemate, is the racemic open-chain carboxylic acid related to the pyrrolidone parent drug. CAS 67118-31-4, molecular formula C8H13NO3, molecular weight 171.19 g/mol. It represents a hydrolytic or synthetic degradant arising from ring-opening of the 2-oxopyrrolidine scaffold rather than a reactive genotoxic class. Because it is polar and structurally close to the active substance, its measurement commonly relies on reversed-phase HPLC with UV or LC-MS/MS confirmation, and orthogonal LC-HRMS methods may be required for trace-level impurity profiling in pharmacopoeial and stability studies.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url